LBA72 Nivolumab 3mg/kg and ipilimumab 1mg/kg (nivo3/ipi1) in molecularly selected patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 35; pp. S1259 - S1260
Main Authors Mehra, N., Van Wilpe, S., Westdorp, H., Kloots, I., Slootbeek, P., Brok, M. den, Franken, M., Coskuntürk, M., Bloemendal, H., Nagarajah, J., van Ipenburg, J., Kroeze, L., Ligtenberg, M., Schalken, J.A., Gerritsen, W.R.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2024
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/j.annonc.2024.08.2315